The type dimension of the X‑Ray Protective Facial Screen market is divided into four principal sub‑categories: lead‑based, non‑lead (e.g., bismuth‑based), composite, and disposable screens. Lead‑based screens continue to dominate due to their established attenuation performance, accounting for roughly 45 % of total revenue despite regulatory pressure for alternatives. Non‑lead screens, driven by health‑safety mandates and lighter weight, capture about 30 % of the market, with a growth rate that exceeds the overall market CAGR. Composite screens, which blend lead with polymer matrices, occupy near 15 % of sales, offering a balance between protection and ergonomics. Disposable screens, primarily used in high‑turnover clinical settings, represent the remaining 10 % and are expanding as infection‑control protocols tighten. Together, these type segments shape the overall market size by allocating capital, R&D focus, and supply‑chain resources, illustrating the nuanced X‑Ray Protective Facial Screen segmentation that manufacturers must navigate.